Project Grant R43JG000003
Award Date 9/30/25
Completion Date 3/31/26
Dollars Obligated $300K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $265,850 Project Grant to SKM Instruments, LLC on Sep 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant supports the development of an ULTRA-RAPID OPTICAL PLATFORM FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) OF PULMONARY NON-TUBERCULOUS MYCOBACTERIAL (NTM) INFECTIONS. The project aims to create an innovative health technology to enhance disease detection and prevention...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $233,666 Project Grant to Esper Biosciences Inc. in Ithaca, NY on September 30, 2025 under the CDC Investigations and Technical Assistance program (CFDA 93.283). The grant funding supports the development of a rapid point-of-care nucleic acid test for Hepatitis C using nanosensors. This project aligns with the CDC program's goals of controlling communicable diseases and developing innovative health technologies. The award has...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $279,270 Project Grant to Advanced Virology Inc. in Philadelphia, PA on September 30, 2025. The grant, funded through the CDC's Investigations and Technical Assistance program (CFDA 93.283), supports the development of "LOW-COST AND HIGH EFFICIENCY DNA-BASED REVERSE GENETICS PLATFORMS FOR MANUFACTURING RNA VIRUS PRODUCTS." The project aims to advance technologies for the production of RNA virus-based products through...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,047,807 Project Grant under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Nanohmics Inc., a small technology development company based in Austin, TX. The grant, with a performance period from September 30, 2025 to September 29, 2027, supports the development of Lateral Flow-Electrochemiluminescent (LF-ECL) test strips and a portable reader system for ultrasensitive detection of foodborne...
- This $1,993,374 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) HIV Prevention Activities Health Department Based program (CFDA 93.940) supports the Georgia Department of Public Health's (GDPH) Tuberculosis Elimination and Laboratory program. The program provides a range of services to reduce tuberculosis (TB) morbidity and mortality in Georgia, including: Medical consultation and case management for confirmed and presumed TB cases Laboratory services...
- The federal Project Grant award of $3,089,360 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development and evaluation of innovative tuberculosis (TB) diagnostic platforms and assays. The 5-year project, awarded to Rutgers, The State University of New Jersey, aims to accelerate promising TB diagnostics through a fast-paced pipeline that includes technology scouting, development...
- The Centers for Disease Control and Prevention (CDC) has awarded a 5-year, $1,501,317 Tuberculosis Elimination and Laboratory Cooperative Agreement (CFDA 93.116) to the Massachusetts Department of Public Health (MDPH). The project aims to prevent, control, and alleviate the burden of tuberculosis (TB) among at-risk populations in Massachusetts, particularly racial/ethnic minorities and non-U.S.-born individuals, in response to a 2023 surge in TB cases. Key strategies include TB case diagnosis...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $501,200 Project Grant on Sep 30, 2025 to Aptus Biosciences LLC, a minority-owned small business located in Gainesville, Florida, under the CDC's "Prevention of Disease, Disability, and Death by Infectious Diseases" program (CFDA 93.084). The funding will support the development of a rapid, affordable, aptamer-based diagnostic test for Hepatitis C virus. Aptus Biosciences specializes in advanced diagnostic research and...
- This $288,023 federal Project Grant was awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The grant was awarded on July 1, 2025 to the University of Vermont & State Agricultural College to study the feasibility and acceptability of tele-exercise to improve physical function in World Trade Center responders with prostate cancer. The funding will support research, surveillance, and technical assistance...
- The District of Columbia Department of Health (DC Health) was awarded a $79,158 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116). The purpose of this 5-year award, running from January 1, 2025 to December 31, 2029, is to execute activities that will contribute to the prevention, control, and eventual elimination of tuberculosis (TB) in the District of Columbia. Key...